BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31900813)

  • 1. "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.
    Fridman I; Ubel PA; Blumenthal-Barby J; England CV; Currier JS; Eyal N; Freedberg KA; Halpern SD; Kelley CF; Kuritzkes DR; Le CN; Lennox JL; Pollak KI; Zikmund-Fisher BJ; Scherr KA
    AIDS Behav; 2020 Jul; 24(7):2054-2061. PubMed ID: 31900813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States.
    Dubé K; Taylor J; Sylla L; Evans D; Dee L; Burton A; Willenberg L; Rennie S; Skinner A; Tucker JD; Weiner BJ; Greene SB
    PLoS One; 2017; 12(1):e0170112. PubMed ID: 28122027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options.
    Dubé K; Campbell DM; Perry KE; Kanazawa JT; Saberi P; Sauceda JA; Poteat T; Evans D
    AIDS Res Hum Retroviruses; 2020 Dec; 36(12):1054-1058. PubMed ID: 32829645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.
    Dubé K; Eskaf S; Evans D; Sauceda J; Saberi P; Brown B; Averitt D; Martel K; Meija M; Campbell D; Barr L; Kanazawa J; Perry K; Patel H; Luter S; Poteat T; Auerbach JD; Wohl DA
    AIDS Res Hum Retroviruses; 2020 Apr; 36(4):324-348. PubMed ID: 31608651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. If We Build It, Will They Come? Perceptions of HIV Cure-Related Research by People Living with HIV in Four U.S. Cities: A Qualitative Focus Group Study.
    Sylla L; Evans D; Taylor J; Gilbertson A; Palm D; Auerbach JD; Dubé K
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):56-66. PubMed ID: 29198134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What risk of death would people take to be cured of HIV and why? A survey of people living with HIV.
    Murray BR; Kratka A; Scherr KA; Eyal N; Blumenthal-Barby J; Freedberg KA; Kuritzkes DR; Hammitt JK; Edifor R; Katz MN; Pollak KI; Zikmund-Fisher BJ; Halpern SD; Barks MC; Ubel PA
    J Virus Erad; 2019 Apr; 5(2):109-115. PubMed ID: 31191914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Cure Research: Risks Patients Expressed Willingness to Accept.
    Kratka A; Ubel PA; Scherr K; Murray B; Eyal N; Kirby C; Katz MN; Holtzman L; Pollak K; Freedburg K; Blumenthal-Barby J
    Ethics Hum Res; 2019 Nov; 41(6):23-34. PubMed ID: 31743627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of Equipoise, Risk-Benefit Ratios, and "Otherwise Healthy Volunteers" in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative Inquiry.
    Dubé K; Dee L; Evans D; Sylla L; Taylor J; Brown B; Miller V; Corneli A; Skinner A; Greene SB; Tucker JD; Rennie S
    J Empir Res Hum Res Ethics; 2018 Feb; 13(1):3-17. PubMed ID: 28984168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with complementary therapy use in people living with HIV/AIDS receiving antiretroviral therapy.
    Chang BL; van Servellen G; Lombardi E
    J Altern Complement Med; 2003 Oct; 9(5):695-710. PubMed ID: 14629847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical considerations for HIV cure-related research at the end of life.
    Dubé K; Gianella S; Concha-Garcia S; Little SJ; Kaytes A; Taylor J; Mathur K; Javadi S; Nathan A; Patel H; Luter S; Philpott-Jones S; Brown B; Smith D
    BMC Med Ethics; 2018 Oct; 19(1):83. PubMed ID: 30342507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV/AIDS-related stigma felt by people living with HIV from Buea, Cameroon.
    Jacobi CA; Atanga PN; Bin LK; Mbome VN; Akam W; Bogner JR; Kropf S; Malfertheiner P
    AIDS Care; 2013; 25(2):173-80. PubMed ID: 22852551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US.
    Dubé K; Evans D; Sylla L; Taylor J; Weiner BJ; Skinner A; Thirumurthy H; Tucker JD; Rennie S; Greene SB
    J Virus Erad; 2017 Jan; 3(1):40-50.e21. PubMed ID: 28275457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothetical questionnaires may overestimate willingness to participate in HIV cure research: Comparison of a cross-sectional survey to actual willingness to participate in an HIV cure study in the Netherlands.
    Prins HAB; Paulus MR; Rokx C; Been SK; Verbon A
    J Virus Erad; 2020 Nov; 6(4):100014. PubMed ID: 33294213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The willingness of patients with gastroparesis to take risks with medications.
    Navas CM; Crowell MD; Lacy BE
    Aliment Pharmacol Ther; 2019 Feb; 49(4):429-436. PubMed ID: 30628106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS.
    Proctor VE; Tesfa A; Tompkins DC
    AIDS Patient Care STDS; 1999 Sep; 13(9):535-44. PubMed ID: 10813033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing hypothetical willingness from behavioral intentions to initiate HIV pre-exposure prophylaxis (PrEP): Findings from a large cohort of gay and bisexual men in the U.S.
    Rendina HJ; Whitfield TH; Grov C; Starks TJ; Parsons JT
    Soc Sci Med; 2017 Jan; 172():115-123. PubMed ID: 27866750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect Benefits in HIV Cure Clinical Research: A Qualitative Analysis.
    Gilbertson A; Kelly EP; Rennie S; Henderson G; Kuruc J; Tucker JD
    AIDS Res Hum Retroviruses; 2019 Jan; 35(1):100-107. PubMed ID: 30009625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of and factors associated with depression among people living with HIV in France.
    Feuillet P; Lert F; Tron L; Aubriere C; Spire B; Dray-Spira R;
    HIV Med; 2017 Jul; 18(6):383-394. PubMed ID: 27625202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes, Beliefs, and Willingness Toward the Use of mHealth Tools for Medication Adherence in the Florida mHealth Adherence Project for People Living With HIV (FL-mAPP): Pilot Questionnaire Study.
    Morano JP; Clauson K; Zhou Z; Escobar-Viera CG; Lieb S; Chen IK; Kirk D; Carter WM; Ruppal M; Cook RL
    JMIR Mhealth Uhealth; 2019 Jul; 7(7):e12900. PubMed ID: 31271150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and predictors of diabetes mellitus among persons living with HIV: a retrospective cohort study conducted in 4 public healthcare facilities in KwaZulu-Natal.
    Umar DM; Naidoo P
    BMC Public Health; 2021 Feb; 21(1):288. PubMed ID: 33541316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.